{"nct_id":"NCT00706238","title":"MAGE-A3 Antigen-Specific Cancer Immunotherapeutic in Patients With Progressive Metastatic Cutaneous Melanoma","status":"TERMINATED","status_verified_date":"2020-09","start_date":"2008-09-29","start_date_type":"ACTUAL","primary_completion_date":"2011-01-19","primary_completion_date_type":"ACTUAL","completion_date":"2011-01-19","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}